Mixed COVID vaccine schedules offer stronger boost after Sinovac regimen – study
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
(Reuters) – Giving COVID-19 vaccines from either AstraZeneca-Oxford, Pfizer-BioNTech or Johnson & Johnson as a booster after two doses of the COVID-19 inactivated-virus vaccine from Sinovac,
leads to significantly higher antibodies, a study has found.
The best response was seen when an RNA vaccine was given as a booster after the standard schedule of Sinovac’s CoronaVac, researchers from Oxford University said on Monday, adding that the
responses were seen against the Delta and Omicron coronavirus variants too.
(Reporting by Aby Jose Koilparambil and Pushkala Aripaka in Bengaluru; Editing by Ramakrishnan M.)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.